Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Study of Isosorbide Oral Solution in the Treatment of Meniere's Disease

NCT06765993 is registered in ClinicalTrials.gov with Lunan Better Pharmaceutical Co., LTD. as lead sponsor.

NCT NCT06765993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06765993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Study of Isosorbide Oral Solution in the Treatment of Meniere's Disease
Lead sponsor
Lunan Better Pharmaceutical Co., LTD.
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
December 30, 2024
Completion date
December 30, 2027
Enrollment
234 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

meniere´s disease